The microbiome as a source of new enterprises and job creation: Considering clinical faecal and synthetic microbiome transplants and therapeutic regulation
Microb Biotechnol
.
2017 Jan;10(1):4-5.
doi: 10.1111/1751-7915.12597.
Epub 2017 Jan 4.
Authors
Daniel van der Lelie
1
,
Safiyh Taghavi
1
,
Christopher Henry
1
2
3
,
Jack A Gilbert
1
4
5
Affiliations
1
Gusto Global LLC, 5960 Fairview Road, Suite 400, Charlotte, NC, 28210, USA.
2
Argonne National Laboratory, Mathematical and Computer Sciences, 9700 S Cass Avenue, Lemont, IL, 60439, USA.
3
Computation Institute, University of Chicago, Chicago, IL, 60637, USA.
4
The Microbiome Center, Bioscience Division, Argonne National Laboratory, 9700 S Cass Ave., Lemont, IL, 60439, USA.
5
The Microbiome Center, Department of Surgery, University of Chicago, Chicago, IL, 60637, USA.
PMID:
28052560
PMCID:
PMC5270749
DOI:
10.1111/1751-7915.12597
No abstract available
Publication types
Editorial
MeSH terms
Fecal Microbiota Transplantation / methods*
Fecal Microbiota Transplantation / standards*
Gastrointestinal Microbiome*
Health Policy*
Humans
Microbiota*
Transplants / standards*